期刊文献+

真武汤加减治疗心肾阳虚型慢性心衰临床观察 被引量:6

Clinical Observation on Modified Zhenwu Decoction on Chronic Heart Failure of Heart and Kidney Yang Deficiency
下载PDF
导出
摘要 目的探讨在开展心肾阳虚型慢性心衰治疗工作期间,观察真武汤加减治疗方法的应用价值。方法选择我院2015年5月—2017年9月收治的70例心肾阳虚型慢性心衰患者作为实验对象;由数字奇偶法对所有心肾阳虚型慢性心衰患者分组;对照组(35例)选择依那普利+呋塞米+地高辛片药物施治;观察组(35例)选择真武汤加减方法施治;最终就2组心肾阳虚型慢性心衰患者的心功能疗效、射血分数、中医证候疗效与N端脑利钠肽水平展开对比。结果同对照组心肾阳虚型慢性心衰患者心功能疗效、射血分数、中医证候疗效与N端脑利钠肽水平展开对比,观察组心肾阳虚型慢性心衰患者获得显著改善(P<0.05)。结论合理应用真武汤加减方法施治,显著能够改善患者心功能疗效、射血分数、中医证候疗效与N端脑利钠肽水平,从而优化心肾阳虚型慢性心衰患者的预后能力以及生活能力。 Objective To explore the application value of modified Zhenwu decoction on chronic heart failure of heart and kidney yang deficiency. Methods A total of 70 patients with chronic heart failure (CHD) were enrolled in our hospital from May 2015 to September 2017. Patients with chronic heart failure were randomly divided into control group (35 eases) used enalapril, furosemide and digoxin tablets during clinical heart and kidney yang deficiency in the treatment of chronic heart failure during treatment and observation group (35 cases) applied Zhenwu decoction during clinical development of heart and kidney yang type of chronic heart failure treatment. The cardiac function, ejection fraction, TCM syndrome and N-terminal brain natriuretic peptide levels between the two groups was compared. Results Comparing with the control group, the curative effect of cardiac function, ejection fraction, TCM syndromes and N-terminal brain natriuretic peptide in the observation group were significantly improved ( P 〈 0.05 ). Conclusion The clinical application of Zhenwu decoction can significantly promote cardiac function, ejection fraction, TCM syndrome and N-terminal brain natriuretic peptide, and thus optimize the prognosis and living ability.
出处 《光明中医》 2018年第4期511-513,共3页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 真武汤加减 心肾阳虚型慢性心衰 中医药疗法 Zhenwu decoction Chronic heart failure of heart and kidney yang deficiency Clinical effect Therapy of TCM
  • 相关文献

参考文献5

二级参考文献28

  • 1王永年.心衰宁汤治疗心肾阳虚型慢性心力衰竭35例[J].陕西中医,2008,29(10):1287-1288. 被引量:5
  • 2丁大植,沈铁宽,崔银泽,李仙女,金红梅,金春玉,丁淑,韩娜.红参对充血性心力衰竭的疗效及其作用机理的研究[J].中国中西医结合杂志,1995,15(6):325-327. 被引量:90
  • 3黄汉超,周凤娇,陈宏珪,冼绍祥.中西医结合治疗慢性充血性心力衰竭述评[J].辽宁中医学院学报,2006,8(2):50-53. 被引量:5
  • 4陈兆善,胡婉英,赵卫,董耀荣,周华.鹿角方对慢性心力衰竭患者左室重构的干预作用[J].上海中医药杂志,2006,40(4):13-15. 被引量:17
  • 5中华医学会心血管病学分会.中华心血管病杂志编辑委员会慢性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23.
  • 6徐振亚,陈景礼,薛兰英,等.心血管病的诊断和治疗[M].北京:科学出版社,2000:196-197.
  • 7陈灏珠.内科学4版[M].北京:人民卫生出版社,1996:136.
  • 8Hjalmarson FG. Effects of controlled-release metropolis on total mortality, hospitalization, and well-being in patients with heart failure, The metoprolol CR/XLR and omized international trial in congestive heart failure (MERI-HF) [J].JAm Med Assoc, 2000, 283: 259-302.
  • 9Sehrier RW. Role of diminished renal function in cardiovascular mortality: maker or path genetic factory [J]. J Am Coll Cardiol, 2006. 47 (1) : 1-8.
  • 10LBongartz LG, Cramer M J, Doevendans PA, et al. The severe cardiorenal syndrome: guyton revisited[J].Eur Heart J, 2005, 26(11): 11-17.

共引文献27

同被引文献78

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部